1. 0500 Evaluation of the Human Abuse Potential of Single Oral Doses of V117957, a Novel, Highly Potent and Selective Partial Agonist for Nociceptin/Orphanin-FQ Peptide (NOP) Receptors. (27th May 2020) Authors: Harris, S; Zhou, M; Cipriano, A; Kapil, R; Shet, M; He, E; Apseloff, G Journal: Sleep Issue: Volume 43(2020)Supplement 1 Page Start: A191 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 0502 Safety, Tolerability, and Efficacy of a Novel, Highly Potent and Selective Partial Agonist for Nociceptin/Orphanin-FQ Peptide (NOP) Receptors in Patients with Insomnia Disorder. (27th May 2020) Authors: Zhou, M; Harris, S; Kapil, R; Cipriano, A; He, E; Shet, M; Fukumura, K; Matsuo, Y; Uehira, M; Zammit, G Journal: Sleep Issue: Volume 43(2020)Supplement 1 Page Start: A192 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. 0198 Psychomotor/Cognitive Effects, Pharmacokinetics and Safety of V117957, a Novel, Highly Potent and Selective Partial Agonist for Nociceptin/Orphanin-FQ Peptide (NOP) Receptors, Administered in Combination with Alcohol in Healthy Subjects. (27th May 2020) Authors: Zhou, M; Harris, S; Cipriano, A; Kapil, R; He, E; Shet, M; Apseloff, G Journal: Sleep Issue: Volume 43(2020)Supplement 1 Page Start: A78 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗